PradipKRustagiMD

PubMed

• 1274 citations
  Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B
  Amit C. Nathwani, Edward G. D. Tuddenham, Savita Rangarajan, Cecilia Rosales, Jenny McIntosh, David C. Linch, Pratima Chowdary, Anne Riddell, Arnulfo Jaquilmac Pie, Ch...> ;The New England Journal of Medicine. 2011 Dec 21
• 1536 citations
  Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response
  Catherine S. Manno, Glenn F. Pierce, Valder R. Arruda, Bertil Glader, Margaret V. Ragni, Rasko Jj, Margareth C. Ozelo, Keith Hoots, Blatt P, Barbara A. Konkle, Michael...> ;Nature Medicine. 2006 Feb 12
• Clinical application of the activated partial thromboplastin time (APTT) with modified incubation time for the diagnosis of lupus anticoagulant (LA)
  Patricia Fardella, Pradip K Rustagi> ;Annals of the New York Academy of Sciences. 2004 Apr 1
• 39 citations
  Effects of synthetic oligonucleotides on human complement and coagulation
  Denise R. Shaw, Pradip K. Rustagi, Ekambar R. Kandimalla, Adrienne Manning, Zhiwei Jiang, Sudhir Agrawal> ;Biochemical Pharmacology. 1997 Apr 25
• 10 citations
  Biological activity of 26-succinylbryostatin 1
  Gary S. Bignami, Fred Wagner, Paul G. Grothaus, Pradip K. Rustagi, Dana E. Davis, Andrew S. Kraft> ;Biochimica Et Biophysica Acta. 1996 Jul 24
• 15 citations
  Reversible Prolonged Skin Bleeding Time in Acute Gastrointestinal Bleeding Presumed Due to Nsaids
  John P. Day, Angel Lanas, Pradip Rustagi, Basil I. Hirschowitz> ;Journal of Clinical Gastroenterology. 1996 Mar 1
• 14 citations
  Novel enzymatic and immunological responses to oligonucleotides.
  Sudhir Agrawaf, Pradip K. Rustagi, Denise R. Shaw> ;Toxicology Letters. 1995 Dec 1
• 35 citations
  In Vivo Administration of the Anticancer Agent Bryostatin 1 Activates Platelets and Neutrophils and Modulates Protein Kinase C Activity
  Roger L. Berkow, Larry Schlabach, Robert W. Dodson, William H. Benjamin, George R. Pettit, Pradip K. Rustagi, Andrew S. Kraft> ;Cancer Research. 1993 Jun 15
• 8 citations
  Light chain composition of serum granulocyte binding immunoglobulins.
  Kaushik A. Shastri, Brian M. O'Connor, Gerald Logue, David S. Shimm, Pradip K. Rustagi> ;American Journal of Hematology. 1991 Jul 1
• 26 citations
  Hemorrhagic disorder due to an isoniazid-associated acquired factor XIII inhibitor in a patient with waldenström's macroglobulinemia
  Richard Krumdieck, Denise R. Shaw, Shu T. Huang, Man-Chiu Poon, Pradip K. Rustagi> ;The American Journal of Medicine. 1991 May 1
• Missed diagnosis?
  Rathbun JM, Rustagi P> ;Hosp Community Psychiatry. 1989-10-01
• 7 citations
  Effect of RBCs on the activation of human complement by heparin-protamine complexes.
  Kaushik A. Shastri, Matthew J. Phillips, Syed T. Raza, Gerald L. Logue, Pradip K. Rustagi> ;Blood. 1988 Jan 1
• 19 citations
  Granulocyte antibodies in leukaemic chronic lymphoproliferative disorders
  P. K. Rustagi, Tin Han, L. Ziolkowski, D. L. Farolino, M. S. Currie, G. L. Logue> ;British Journal of Haematology. 1987 Aug 1
• 35 citations
  Complement-mediated autoimmune thrombocytopenia. Monoclonal IgM antiplatelet antibody associated with lymphoreticular malignant disease.
  Harold A. Lehman, Leorosa O. Lehman, Pradip K. Rustagi, Rajendra N. Rustgi, Richard W. Plunkett, Deborah L. Farolino, James B. Conway, Gerald L. Logue> ;The New England Journal of Medicine. 1987 Jan 22
• 6 citations
  Teardrop-shaped red cells in autoimmune hemolytic anemia
  Deborah L. Farolino, Pradip K. Rustagi, Mark S. Currie, Thomas D. Doeblin, Gerald L. Logue> ;American Journal of Hematology. 1986 Apr 1
• 24 citations
  Complement-activating antineutrophil antibody in systemic lupus erythematosus
  Pradip K. Rustagi, Mark S. Currie, Gerald L. Logue> ;The American Journal of Medicine. 1985 Jun 1
• 11 citations
  T‐lymphocytes escape membrane defect in paroxysmal nocturnal haemoglobinuria
  Michael R. Cooper, Mark S. Currie, Pradip K. Rustagi, Gerald L. Logue> ;British Journal of Haematology. 1983 Oct 1
• 20 citations
  Activation of human complement by immunoglobulin G antigranulocyte antibody.
  Pradip K. Rustagi, Mark S. Currie, Gerald L. Logue> ;The Journal of Clinical Investigation. 1982 Dec 1
• 4 citations
  Phagocytosis of technetium-99m sulfur colloid by human polymorphonuclear leukocytes.
  Pradip K. Rustagi, Albert F. LoBuglio> ;Journal of Immunological Methods. 1978 Sep 1
• 141 citations
  Human granulocyte generation of hydroxyl radical.
  Stephen J. Weiss, Pradip K. Rustagi, Albert F. LoBuglio> ;The Journal of Experimental Medicine. 1978 Feb 1
• Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.
  Lewis, B. E., Wallis, D. E., Berkowitz, S. D., Matthai, W. H., Fareed, J., Walenga, J. M., Bartholomew, J., Sham, R., Lerner, R. G., Zeigler, Z. R., Rustagi, P. K., Ja...> ;Circulation. 2001 Apr 10
• Differential diagnosis of schizophrenia and multiple personality disorder.
  Rathbun, J. M., Rustagi, P. K.> ;Am J Psychiatry. 1990 Mar
• Mnemonic device for criteria for borderline personality disorder.
  Powers, A. D., Rustagi, P. K.> ;Am J Psychiatry. 1989 Nov
• Effect of antigen site and complement receptor status on the rate of cleavage of C3c antigen from red cell bound C3b.
  Currie, M. S., Rustagi, P. K., Wojcieszak, R., Ziolkowski, L., Ross, G. D., Logue, G. L.> ;Blood. 1988 Mar
• Diagnosis and treatment of a child with X-polysomy.
  Rustagi, P. K., Fine, P. M.> ;J Am Acad Child Adolesc Psychiatry. 1987 Jul
• Join now to see all

Journal Articles

• Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host response  
  Manno CS, Pierce GF, Arruda VR, Glader B, Ragni M, Rasko JJ, Ozelo MC, Hoots K, Blatt P, Konkle B, Dake M, Kaye R, Razavi M, Zajko A, Zehnder J, Rustagi PK, Nakai H, C..., Nature Med, 1/1/2006
• Aplicacion del tiempo de tromboplastina parcial activado (TTPA) con tiempo de incubacion modificado en el diagnostico del anticoagulante lupico (AL)  
  Fardella P, Rustagi PK, Rev Med Chile, 1/1/2004
• ARG-911 Study Investigators Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia  
  Lewis BE, Wallis DE, Berkowitz SD, Matthai WH, Fareed J, Walenga JM, Bartholomew J, Sham R, Lerner RG, Zeigler ZR, Rustagi PK, Jang IK, Rifkin SD, Moran J, Hursting MJ..., Circulation, 1/1/2001
• Increased platelet activation and fibrinogen in Asian Indians: potential implications for coronary risk  
  Markovitz JH. Kulkarni K, Goldschmidt-Clermont F, Kiefe CI, Rustagi P, Sekar P, Nanda N, Eur Heart J, 1/1/1998
• Multicentric evaluation of heparinase on aPTT, thrombin clotting time and a new PT reagent based on recombinant human tissue factor  
  Harenberg J, Reichel Th, Malsch R, Hirsh J, Rustagi P, Blood Coag Fibrinol, 1/1/1996
• Novel enzymatic and immunological responses to oligonucleotides  
  Agrawal S, Rustagi PK, Shaw DR, Toxicol Letters, 1/1/1995
•  
  Warner KJ, Blackwell GG, Herrera GA, Listinsky C, Holman WL, Rustagi PK, Arch Pathol Lab Med, 1/1/1994
• Clinical study of recovery and half-life of vapor-heated factor VII concentrate  
  Rivard GE, Kovac I, Kunschak M, Thöne P, The Factor VII Study Group, Transfusion, 1/1/1994
• Type IIB mutation His-505 -> Asp implicates a new segment in the control of von Willebrand factor binding to platelet glycoprotein Ib  
  Rabinowitz I, Randi AM, Shindler KS, Tuley EA, Rustagi PK, Sadler JE, J Biol Chem, 1/1/1993
• Markers of the activation of coagulation/thrombophilia  
  Rustagi PK, Triplett DA, ClinChem News, 1/1/1992
• Hemorrhagic disorder due to an isoniazid-associated acquired factor XIII inhibitor in a patient with Waldenström’s macroglobulinemia  
  Krumdieck R, Shaw DR, Huang ST, Poon M-C, Rustagi PK, Am J Med, 1/1/1991
• Antibodies to granulocyte precursors in selective myeloid hypoplasia and other suspected autoimmune neutropenias: the use of HL-60 cells as targets  
  Currie MS, Weinberg JB, Rustagi PK, Logue GL, Blood, 1/1/1987
• Neutropenia associated with b-lactam antibiotics  
  Kirkwood CF, Smith LL, Rustagi PK, Schentag JJ, ClinPharm, 1/1/1983
• Phagocytosis of technetium-99m sulfur colloid by human polymorphonuclear leukocytes  
  Rustagi PK, LoBuglio AF, J Immunol Meth, 1/1/1978
• Join now to see all

Books/Book Chapters

• Anticoagulant, Antithrombotic, and Thrombo­lytic Therapeutics II 
  Chapter: Development of novel, broad spectrum serine protease inhibitors for use as anticoagulants 
  Page 307 - 320Rustagi PK, Kilpatrick JM, Niwas S. Szalai A, Babu YSInternational Business Communications, Inc, Southborough, MA1998
• Women’s Medicine 
  Chapter: Coagulation disorders 
  Page 213 - 235Rustagi PKEditors: Richard E. Blackwell.Blackwell Science, Inc., Cambridge1996
• Internal Medicine 
  Chapter: Blood transfusion 
  Page 1 - 965Rustagi PK, Logue GLEditors: Jay H. Stein.Little Brown and Company, Boston, MAEdition 2nd,1987